PMC:7376974 / 82473-82803 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T387","span":{"begin":198,"end":211},"obj":"Body_part"},{"id":"T388","span":{"begin":232,"end":240},"obj":"Body_part"},{"id":"T389","span":{"begin":254,"end":258},"obj":"Body_part"}],"attributes":[{"id":"A387","pred":"fma_id","subj":"T387","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A388","pred":"fma_id","subj":"T388","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A389","pred":"fma_id","subj":"T389","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":198,"end":211},"obj":"Body_part"},{"id":"T26","span":{"begin":254,"end":258},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1481","span":{"begin":279,"end":282},"obj":"Chemical"},{"id":"1486","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"1487","span":{"begin":137,"end":146},"obj":"Disease"},{"id":"1488","span":{"begin":254,"end":271},"obj":"Disease"},{"id":"1489","span":{"begin":321,"end":330},"obj":"Disease"}],"attributes":[{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"MESH:D017382"},{"id":"A1486","pred":"tao:has_database_id","subj":"1486","obj":"MESH:D007239"},{"id":"A1487","pred":"tao:has_database_id","subj":"1487","obj":"MESH:D007239"},{"id":"A1488","pred":"tao:has_database_id","subj":"1488","obj":"MESH:D011014"},{"id":"A1489","pred":"tao:has_database_id","subj":"1489","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T227","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"T228","span":{"begin":137,"end":146},"obj":"Disease"},{"id":"T229","span":{"begin":259,"end":271},"obj":"Disease"},{"id":"T230","span":{"begin":321,"end":330},"obj":"Disease"}],"attributes":[{"id":"A227","pred":"mondo_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A228","pred":"mondo_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A229","pred":"mondo_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A230","pred":"mondo_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T759","span":{"begin":77,"end":82},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T760","span":{"begin":198,"end":211},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T761","span":{"begin":254,"end":258},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T762","span":{"begin":254,"end":258},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T418","span":{"begin":279,"end":282},"obj":"Chemical"}],"attributes":[{"id":"A99457","pred":"chebi_id","subj":"T418","obj":"http://purl.obolibrary.org/obo/CHEBI_26523"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T194","span":{"begin":259,"end":271},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}

{"project":"2_test","denotations":[{"id":"32667191-32402576-153385","span":{"begin":147,"end":150},"obj":"32402576"}],"text":"ility to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection"}